Perla, Yollinda C.
HRN: 01-62-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/06/2023
06/08/2023
IV
500 Mg
Every 8 Hours For 6 Doses
S/P Repeat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive TractProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes